Article
Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China.
Pharmacogenomics - 1 May 2022
Liu Wenpei, Lu Lihuan, Pan Hongqiu, He Xiaomin, Zhang Meiling, Wang Nannan, Zhu Jia, Yi Honggang, Tang Shaowen
Abstract excerpt
Objective: To assess whether the risk of anti-tuberculosis drug-induced hepatotoxicity (ATDH) might be influenced by heme oxygenase-1 (HMOX1) and hemopexin (HPX) gene polymorphisms. Methods: A dynamic anti-tuberculosis treatment cohort was constructed, and the 1:4 matched nested case-control study was analysed. Eight single-nucleotide polymorphisms (SNPs) of the two genes were selected for genotyping and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
